11 – 20 of 63
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Glucose-6-phosphate-dehydrogenase on old peroxisomes maintains self-renewal of epithelial stem cells after asymmetric cell division
- Contribution to journal › Article
-
Mark
Validation of a breast cancer assay for radiotherapy omission : an individual participant data meta-analysis
- Contribution to journal › Article
-
Mark
Racial variation in the advanced prostate cancer genome
- Contribution to journal › Article
-
Mark
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels
- Contribution to journal › Article
-
Mark
Identifying prognostic targets in metastatic prostate cancer beyond AR
- Contribution to journal › Article
-
Mark
Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferation
- Contribution to journal › Article
- 2024
-
Mark
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
- Contribution to journal › Article
-
Mark
Clinical cell-surface targets in metastatic and primary solid cancers
- Contribution to journal › Article
-
Mark
PVT1 interacts with polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma
- Contribution to journal › Article
-
Mark
The analytical and clinical validity of AI algorithms to score TILs in TNBC : can we use different machine learning models interchangeably?
- Contribution to journal › Article
